Year |
Citation |
Score |
2022 |
Gähler A, Trufa DI, Chiriac MT, Tausche P, Hohenberger K, Brunst AK, Rauh M, Geppert CI, Rieker RJ, Krammer S, Leberle A, Neurath MF, Sirbu H, Hartmann A, Finotto S. Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma. Frontiers in Oncology. 12: 873293. PMID 35574343 DOI: 10.3389/fonc.2022.873293 |
0.358 |
|
2017 |
Chen D, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget. 8: 51164-51176. PMID 28881638 DOI: 10.18632/Oncotarget.17737 |
0.666 |
|
2017 |
Dahlmanns M, Yakubov E, Chen D, Sehm T, Rauh M, Savaskan N, Wrosch JK. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030. PMID 28835855 DOI: 10.1038/Cddiscovery.2017.30 |
0.573 |
|
2017 |
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 6: e371. PMID 28805788 DOI: 10.1038/oncsis.2017.65 |
0.642 |
|
2017 |
Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene. PMID 28553953 DOI: 10.1038/Onc.2017.146 |
0.68 |
|
2017 |
Chen D, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget. PMID 28538211 DOI: 10.18632/oncotarget.17737 |
0.666 |
|
2017 |
Chen J, Chaurio RA, Maueröder C, Derer A, Rauh M, Kost A, Liu Y, Mo X, Hueber A, Bilyy R, Herrmann M, Zhao Y, Muñoz LE. Inosine Released from Dying or Dead Cells Stimulates Cell Proliferation via Adenosine Receptors. Frontiers in Immunology. 8: 504. PMID 28496447 DOI: 10.3389/fimmu.2017.00504 |
0.364 |
|
2016 |
Sehm T, Rauh M, Wiendieck K, Buchfelder M, Eyüpoglu IY, Savaskan NE. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget. PMID 27612422 DOI: 10.18632/Oncotarget.11858 |
0.678 |
|
2016 |
Sehm T, Fan Z, Ghoochani A, Rauh M, Engelhorn T, Minakaki G, Dörfler A, Klucken J, Buchfelder M, Eyüpoglu IY, Savaskan NE. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget. PMID 27074570 DOI: 10.18632/Oncotarget.8651 |
0.677 |
|
2014 |
Wolf IM, Fan Z, Rauh M, Seufert S, Hore N, Buchfelder M, Savaskan NE, Eyüpoglu IY. Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration. Scientific Reports. 4: 6226. PMID 25228443 DOI: 10.1038/Srep06226 |
0.661 |
|
2014 |
Fan Z, Sehm T, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan NE. Dexamethasone alleviates tumor-associated brain damage and angiogenesis. Plos One. 9: e93264. PMID 24714627 DOI: 10.1371/Journal.Pone.0093264 |
0.695 |
|
Show low-probability matches. |